BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 31505044)

  • 21. New therapies for patients with multiple endocrine neoplasia type 1.
    Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
    Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and emerging therapies for PNETs in patients with or without MEN1.
    Frost M; Lines KE; Thakker RV
    Nat Rev Endocrinol; 2018 Apr; 14(4):216-227. PubMed ID: 29449689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study.
    Chiloiro S; Lanza F; Bianchi A; Schinzari G; Brizi MG; Giampietro A; Rufini V; Inzani F; Giordano A; Rindi G; Pontecorvi A; De Marinis L
    Endocrine; 2018 May; 60(2):362-367. PubMed ID: 28567607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
    Kann PH; Balakina E; Ivan D; Bartsch DK; Meyer S; Klose KJ; Behr T; Langer P
    Endocr Relat Cancer; 2006 Dec; 13(4):1195-202. PubMed ID: 17158764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
    Jullien M; Reichert T; D'Anella P; Castinetti F; Barlier A; Brue T; Taieb D; Cuny T
    Ann Endocrinol (Paris); 2020 Feb; 81(1):39-43. PubMed ID: 31982106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
    Ito T; Igarashi H; Uehara H; Berna MJ; Jensen RT
    Medicine (Baltimore); 2013 May; 92(3):135-181. PubMed ID: 23645327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
    Newey PJ; Jeyabalan J; Walls GV; Christie PT; Gleeson FV; Gould S; Johnson PR; Phillips RR; Ryan FJ; Shine B; Bowl MR; Thakker RV
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3640-6. PubMed ID: 19622622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rupture of small cystic pancreatic neuroendocrine tumor with many microtumors.
    Sagami R; Nishikiori H; Ikuyama S; Murakami K
    World J Gastroenterol; 2017 Oct; 23(37):6911-6919. PubMed ID: 29085235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of surgical resection for pancreatic neuroendocrine tumors.
    Doi R
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs.
    van Vliembergen ENM; Eijkelenkamp H; Valk GD; Vriens MR; Meijer GJ; Intven MPW; de Laat JM
    Front Endocrinol (Lausanne); 2023; 14():994370. PubMed ID: 37305036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.
    Mauriello C; Napolitano S; Gambardella C; Candela G; De Vita F; Orditura M; Sciascia V; Tartaglia E; Lanza M; Santini L; Conzo G
    Int J Surg; 2015 Sep; 21 Suppl 1():S10-4. PubMed ID: 26118605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].
    Drbalová K; Herdová K; Krejčí P; Nývltová M; Solař S; Vedralová L; Záruba P; Netuka D; Bavor P
    Vnitr Lek; 2016; 62(9 Suppl 3):140-149. PubMed ID: 27734708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.
    Triponez F; Sadowski SM; Pattou F; Cardot-Bauters C; Mirallié E; Le Bras M; Sebag F; Niccoli P; Deguelte S; Cadiot G; Poncet G; Lifante JC; Borson-Chazot F; Chaffanjon P; Chabre O; Menegaux F; Baudin E; Ruszniewski P; Du Boullay H; Goudet P
    Ann Surg; 2018 Jul; 268(1):158-164. PubMed ID: 28263205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study.
    Kappelle WF; Valk GD; Leenders M; Moons LM; Bogte A; Siersema PD; Vleggaar FP
    Endoscopy; 2017 Jan; 49(1):27-34. PubMed ID: 27975336
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New considerations in the surgical treatment of pancreatic neuroendocrine tumours].
    Farkas G
    Orv Hetil; 2013 Sep; 154(39):1565-8. PubMed ID: 24058102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic insufficiency following pancreatectomy: Does underlying tumor syndrome confer a greater risk?
    McDonald JD; Gupta S; Shindorf ML; Copeland A; Good ML; Sadowski SM; Nilubol N
    Am J Surg; 2021 Feb; 221(2):465-471. PubMed ID: 32943182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complicated Case Presentation: Management of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
    Mulvey CK; Van Loon K; Bergsland EK; Masharani U; Nakakura EK
    Pancreas; 2017 Mar; 46(3):416-426. PubMed ID: 28187108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct Prognostic Factors in Sporadic and Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors.
    Kfir SK; Halperin R; Percik R; Uri I; Halpern N; Shlomai G; Laish I; Tirosh A; Tirosh A
    Horm Metab Res; 2021 May; 53(5):319-325. PubMed ID: 33878789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.